Classical and Non-Classical Compound Combinations for Treatment of Prostate Cancer Cell Line PC3

Classical and Non-Classical Compound Combinations for Treatment of Prostate Cancer Cell Line PC3

Prostate cancer is one of the leading causes of death among men. Our study focuses on seeking new compounds and combinations to diminish the severe side effects of classical anticancer drugs for treating this type of cancer. In this study, we investigated and compared the classical anticancer drug d...

Full description

Saved in:
Bibliographic Details
Main Authors: Lidiya Petrova, Diana Zasheva, Nikolay Gergov, Els J. M. Van Damme, Tsvetelina Oreshkova, Vanya Bogoeva, Teodora Aleksandrova
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Proceedings
Subjects:
Au porphyrin
jacalin
docetaxel
prostate cancer
PC3
apoptosis
Online Access:https://www.mdpi.com/2504-3900/103/1/42
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items